Back to search
FDAFDA · Food and drugs·Recall number Z-3174-2024

STREAMLINE FRESENIUS FOR DAVITA-Tubing to be used to transfer blood between a patient and a haemodialyser during haemodialysis. Model/Catalog Number: SL-2000M2095D

Published September 25, 2024 · Recall initiated: August 15, 2024

Summary

FDA records medical device Class II recall Z-3174-2024, published September 25, 2024 and initiated August 15, 2024. Recalling firm: B Braun Medical Inc; Status: Ongoing; Reported quantity: 4671540 units; Lot: UDI-DI 04046955348763; All Unexpired Lot Numbers. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incomplete insertion of the patient connector of the Streamline Airless System Hemodialysis Bloodline to the Locksite may result in the potential for occlusion during prograde rinseback procedures. If the patient connector is not fully inserted into the Locksite, the internal septum may not open fully enough to prevent restrictions to flow. may cause delays in therapy while clinicians are forced to switch to retrograde flow method

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
B Braun Medical Inc
Distributor
US Nationwide distribution.
Lot
UDI-DI 04046955348763; All Unexpired Lot Numbers
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was STREAMLINE FRESENIUS FOR DAVITA-Tubing to be used to transfer blood between a patient and a haemodialyser during haemodialysis. Model/Catalog Number: SL-2000M2095D recalled?

Yes. FDA published recall Z-3174-2024 on September 25, 2024. Reported hazard: Incomplete insertion of the patient connector of the Streamline Airless System Hemodialysis Bloodline to the Locksite may result in the potential for occlusion during prograde rinseback procedures. If the patient connector is not fully inserted into the Locksite, the internal septum may not open fully enough to prevent restrictions to flow. may cause delays in therapy while clinicians are forced to switch to retrograde flow method

What should I do if I have this product?

Voluntary: Firm initiated · Letter